# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-23-008932
Filing Date
2023-03-22
Accepted
2023-03-22 17:02:09
Documents
1
Period of Report
2023-03-22
Effectiveness Date
2023-03-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | a2022glossyannualreportfil.pdf | ARS | 15742884
| Complete submission text file | 0001628280-23-008932.txt |  | 21437200

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33637 | Film No.: 23753612
SIC: 2834 Pharmaceutical Preparations